This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
SOAT1 / Sterol O-acyltransferase 1 · IHC design guide
Design Immunohistochemistry for SOAT1
Plan chromogenic SOAT1 IHC on paraffin sections using adrenal zona fasciculata cells as a high-staining reference (HPA tissue IHC). The guide covers fixation consistency, staining controls and interpretation of cytoplasmic signal (HPA tissue IHC).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
SOAT1 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Cytoplasmic staining in select cells (HPA tissue IHC) | |
| Staining pattern | Adrenal zona fasciculata and salivary gland cells: cytoplasmic (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A05096-1) | |
| Positive control | Adrenal gland+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep paraffin-section fixation consistent across samples. (standard IHC practice; not target-specific) | |
| Caveat | Staining varies by cell type within a tissue (HPA tissue IHC) | |
| Regulation | No staining-linked regulator annotated (UniProt) | |
| Isoform / epitope | Three isoforms; confirm epitope coverage (UniProt) |
Section 1
Recommended SOAT1 IHC & IF Protocols
The catalog antibody’s IHC-P protocol (datasheet: A05096-1) is followed by four published SOAT1 IHC protocols (PMC8152151; PMC7006231; PMC5811932; PMC9385470).
| Sample | Paraffin-embedded human breast cancer tissue; fixative not specified (datasheet A05096-1) |
| Fixation | Image fixative and duration unreported (datasheet A05096-1); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A05096-1); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A05096-1) |
| Primary antibody | Rabbit anti-SOAT1, 2-5 μg/ml (datasheet A05096-1) |
| Primary incubation | Overnight at 4 °C (datasheet A05096-1) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet A05096-1) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | SOAT1-positive staining in cells in zona fasciculata of adrenal gland (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression in a subset of tissues including adrenal gland, salivary gland, pancreatic ducts, Leydig cells and decidual cells. No signal in the no-primary control. |
💡Decision noteStart with heat-mediated EDTA pH 8.0 retrieval for the catalog antibody (datasheet: A05096-1); the cited citrate protocols used different antibodies (PMC8152151; PMC9385470).
Section 2
What Is the Expected SOAT1 Staining Pattern?
SOAT1 is an endoplasmic reticulum membrane protein with 9 transmembrane segments (UniProt P35610 topology). In paraffin-section IHC, expect cytoplasmic staining in selected cells, especially adrenal zona fasciculata cells, salivary glandular cells, sebaceous glands, decidual cells and intestinal endocrine cells (HPA tissue IHC). HPA rates its tissue profile Enhanced, citing high consistency between staining and RNA expression (HPA tissue IHC).
| Cytoplasmic stain in adrenal zona fasciculata cells, with nearby cells distinguishable by morphology (HPA: High in zona fasciculata). | This fits the reported high-expression positive control and the expected intracellular compartment (HPA tissue IHC; UniProt P35610 subcellular location). Judge staining within identified cells rather than treating the whole section as uniformly positive (general IHC practice). |
| Predominantly nuclear, surface-restricted or extracellular signal in cells scored as positive (UniProt P35610 subcellular location). | Those compartments conflict with the annotated endoplasmic reticulum location and HPA cytoplasmic tissue profile (UniProt P35610; HPA tissue IHC). Check morphology, counterstain and antibody-dependent background before assigning SOAT1 positivity (general IHC practice). |
| Strong stain in adipocytes while the intended positive cells are absent or weak (HPA: adipocytes Not detected). | The adipocyte result conflicts with HPA tissue IHC and raises concern for nonspecific binding or detection-related signal (HPA tissue IHC; general IHC practice). A single discordant cell type does not identify which mechanism is responsible; inspect controls (general IHC practice). |
| Color spreads across stroma, lumina or most cells without clear cellular boundaries (general IHC practice). | A diffuse field cannot be scored confidently as the selective cytoplasmic pattern reported by HPA (HPA tissue IHC). Review the no-primary control, blocking, washes and chromogen development for background (general IHC practice). |
| No stain in adrenal zona fasciculata cells on a section with preserved morphology (HPA: High in zona fasciculata). | A negative known-positive control makes a biological absence call unreliable (HPA tissue IHC; general IHC practice). Check the antibody's IHC-P validation, reagent sequence, retrieval conditions and detection controls before scoring the sample (general IHC practice). |
💡Expected SOAT1 appearanceCall a result positive when staining is cytoplasmic in the relevant cells and clearly strong in a high-expression reference such as adrenal zona fasciculata; isolated nuclear, extracellular or diffuse field staining is suspect (HPA tissue IHC; UniProt P35610; general IHC practice).
| Cell and tissue choice (HPA tissue IHC) | High staining is reported in adrenal zona fasciculata, duodenal and small-intestinal endocrine cells, decidual cells, salivary glandular cells and sebaceous glands; adipocytes are reported Not detected (HPA tissue IHC). Compare like cell types when selecting controls (general IHC practice). |
| Compartment and epitope position (UniProt P35610 topology) | SOAT1 has 9 membrane-spanning segments and both cytoplasmic and lumenal regions (UniProt P35610 topology). The supplied record does not locate the antibody epitope; topology alone cannot predict how a given IHC reagent will stain after retrieval (UniProt P35610 topology; general IHC practice). |
| Antibody validation (HPA antibodies) | HPA lists 2 rabbit polyclonal antibodies, HPA047171 and CAB009533, with Enhanced IHC validation (HPA antibodies). That supports the reported tissue pattern, but agreement still requires matching the stained cell type and compartment in the section being assessed (HPA tissue IHC; general IHC practice). |
| Isoforms and processing (UniProt P35610) | UniProt lists 3 isoforms and a chain spanning residues 1–550, with no annotated signal peptide or propeptide (UniProt P35610). The supplied evidence gives no isoform-specific antibody epitope, so an IHC intensity difference cannot be assigned to a particular isoform (UniProt P35610; general IHC practice). |
| Chromogenic detection background (general IHC practice) | Endogenous enzyme activity can add color when the detection system uses that enzyme (general IHC practice). A no-primary control and the appropriate enzyme-blocking step help distinguish detection signal from antibody-dependent staining (general IHC practice); neither establishes SOAT1-specific reactivity by itself (general IHC practice). |
| Situation | Likely cause | Next action |
|---|---|---|
| High background obscures cell boundaries (general IHC practice). | Incomplete blocking or washing, excessive antibody concentration, or overdevelopment can obscure selective staining (general IHC practice). | Inspect the no-primary control; adjust blocking, washes, antibody concentration and development within the chosen detection workflow (general IHC practice). |
| Adrenal zona fasciculata is blank (HPA: High in zona fasciculata). | A failed staining run or an antibody/retrieval combination that performs poorly in this workflow is possible (general IHC practice). | Target-specific fixation effects are not established by the supplied assay evidence. Verify with a matched IHC source before attributing a result to fixation. |
| Adipocytes stain strongly (HPA: adipocytes Not detected). | The pattern is discordant with the HPA reference; nonspecific antibody or detection signal are possibilities (HPA tissue IHC; general IHC practice). | Compare with a no-primary control and a known-positive cell population; reassess cell identification and antibody dilution before interpreting the signal (general IHC practice). |
| Only nuclei appear positive (UniProt P35610 subcellular location). | Nuclear localization conflicts with the annotated endoplasmic reticulum and HPA cytoplasmic profile (UniProt P35610; HPA tissue IHC). | Recheck counterstain and brightfield color separation, then compare the same run's positive tissue and no-primary control (general IHC practice). |
| A weak section is being called SOAT1-negative (general IHC practice). | HPA reports medium staining in kidney distal tubules and fallopian-tube non-ciliated cells, so intensity varies by cell type (HPA tissue IHC). | Score the named cell population against an appropriate positive control and record intensity and distribution separately (general IHC practice); avoid applying the adrenal high-intensity expectation to every tissue (HPA tissue IHC). |
| IF/ICC: where should signal appear? (HPA subcellular ICC-IF). | HPA reports enhanced endoplasmic reticulum localization by ICC-IF, consistent with UniProt membrane annotation (HPA subcellular ICC-IF; UniProt P35610). | Expect intracellular ER-associated fluorescence rather than a nuclear-only pattern (HPA subcellular ICC-IF; UniProt P35610). Use the separate IF/ICC guide for assay setup (general IHC/IF practice). |
Experiment evidence
IHC & IF images showing SOAT1 staining
A05096-1 · IHCIHC analysis of SOAT1 using anti-SOAT1 antibody (A05096-1). SOAT1 was detected in a paraffin-embedded section of human breast cancer tissue.
A05096-1 · IHCIHC analysis of SOAT1 using anti-SOAT1 antibody (A05096-1). SOAT1 was detected in a paraffin-embedded section of human breast cancer tissue.
A05096-1 · IFIF analysis of SOAT1 using anti-SOAT1 antibody (A05096-1). SOAT1 was detected in an immunocytochemical section of PC-3 cells. Enzyme antigen
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000057252-SOAT1/tissue/cerebral+cortex#imid_18141011
HPA · Adrenal glandHuman Protein Atlas IHC, Adrenal gland. Source: https://www.proteinatlas.org/ENSG00000057252-SOAT1/tissue/adrenal+gland#imid_984
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000057252-SOAT1/tissue/colon#imid_18140953
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000057252-SOAT1/tissue/liver#imid_18140938
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA047171; green = SOAT1, blue = nucleus, red = microtubules.
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA047171; green = SOAT1, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for SOAT1 IHC & IF
🧪Run adrenal gland first: cells in the zona fasciculata should stain (HPA: High in cells in zona fasciculata). Use adipose tissue as the negative tissue, where adipocytes should lack specific staining (HPA: Not detected in adipocytes); on the adrenal slide, assess neighboring non-target cells for background-level signal without assuming that every neighboring cell is SOAT1-negative.
Positive control tissue: Adrenal gland (Cells in zona fasciculata, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show SOAT1 in A-431, U-251MG, U2OS, with annotated localisation: Endoplasmic reticulum (enhanced) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control and concentration-matched nonimmune rabbit IgG, since the selected IHC antibody is rabbit-derived (selected-SKU caption: rabbit anti-SOAT1). A SOAT1 knockout specimen provides a biological negative; quench endogenous peroxidase and check for intrinsic pigment before interpreting DAB signal in adrenal tissue (standard chromogenic IHC practice).
⚠️Feasibility: No target-specific fixation window or fixation effect is reported in the supplied evidence; the selected-SKU tissue-IHC caption does not state a fixative. Its paraffin-section example uses heat-mediated EDTA retrieval at pH 8.0, so start with that retrieval condition while optimizing for adrenal tissue (selected-SKU caption: EDTA pH 8.0). HPA documents an ER pattern in ICC-IF images, but the supplied evidence does not show that frozen sections or IF are easier than paraffin IHC (HPA subcellular: endoplasmic reticulum); intrinsic adrenal pigment can complicate DAB interpretation (standard chromogenic IHC practice).
HPA tissue IHC evidence for SOAT1
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | Cells in zona fasciculata | High | Protein (IHC) | HPA → |
| Duodenum | Endocrine cells | High | Protein (IHC) | HPA → |
| Placenta | Decidual cells | High | Protein (IHC) | HPA → |
| Salivary gland | Glandular cells | High | Protein (IHC) | HPA → |
| Skin | Sebaceous glands | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | Glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebellum | Cells in granular layer | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced SOAT1 IHC Tips
Troubleshoot SOAT1 staining in paraffin-section IHC by checking retrieval, cellular context and controls before comparing staining intensity across samples.
Where should I start if SOAT1 staining is weak in paraffin sections?
Start with heat-mediated antigen retrieval in EDTA at pH 8.0 for SOAT1 paraffin-section IHC (datasheet A05096-1). The reported breast cancer tissue image used this retrieval before a 2 μg/ml primary antibody incubation overnight at 4°C (datasheet A05096-1). Compare retrieved and untreated sections from the same block, keeping detection and development conditions matched (standard IHC practice). If staining remains weak, vary heating duration on adjacent sections and check tissue preservation before considering another buffer as a fallback (standard IHC practice). Score staining within cells rather than interpreting a darker section edge as improved retrieval (standard IHC practice).
How can I assess whether fixation is limiting SOAT1 IHC staining?
Target-specific fixation sensitivity is unknown from the supplied evidence; the selected paraffin-section caption does not state a fixative (datasheet A05096-1). Record each block’s fixative and processing history, then compare similarly processed sections before attributing a weak result to SOAT1 biology (standard IHC practice). Use the same EDTA pH 8.0 retrieval and primary antibody concentration across the comparison (datasheet A05096-1). Include a section with an expected positive cell population, such as adrenal zona fasciculata cells, when available (HPA: High in adrenal zona fasciculata cells). Uneven morphology or staining across a block warrants a processing review, but cannot establish a SOAT1-specific fixation effect (standard IHC practice).
What staining pattern should I expect for SOAT1 in chromogenic IHC?
Expect SOAT1 signal in the cytoplasmic region of positive cells, consistent with its endoplasmic reticulum membrane localisation (UniProt P35610; HPA: cytoplasmic tissue staining). Assess distribution within identifiable cells, since chromogenic IHC does not resolve individual endoplasmic reticulum membranes (standard IHC practice). Adrenal zona fasciculata cells and salivary glandular cells offer reported high-staining populations for comparison (HPA: High in both populations). A convincing result should follow the relevant cell population across the section rather than appear equally in every compartment (standard IHC practice). Predominantly nuclear or extracellular deposits merit a control review before assignment to SOAT1 (UniProt P35610 localisation; standard IHC practice).
Could epitope location explain variable SOAT1 staining after retrieval?
SOAT1 has 3 annotated isoforms and 9 transmembrane segments, so establish which sequence the antibody recognises before interpreting isoform coverage (UniProt P35610). Its annotated cytoplasmic and lumenal stretches make antibody accessibility dependent on the actual epitope, which the supplied caption does not identify (UniProt P35610 topology; datasheet A05096-1). Check the antibody’s immunogen or epitope documentation and compare it with the isoform sequences if available (standard IHC practice). Phosphoserine at position 8 and N-acetylmethionine at position 1 are annotated modifications, but neither establishes a staining effect without epitope evidence (UniProt P35610). Keep retrieval conditions matched while evaluating any antibody comparison (standard IHC practice).
How should I investigate a discrepant SOAT1 IF signal alongside IHC?
Use the dedicated IF/ICC guide for fluorescent staining conditions; interpret the comparison against SOAT1’s endoplasmic reticulum localisation (HPA: enhanced endoplasmic reticulum localisation; UniProt P35610). For multiplex imaging, pair SOAT1 with a validated marker of the expected cell population, such as adrenal zona fasciculata cells, and inspect each channel separately (HPA: High in adrenal zona fasciculata cells; standard IF practice). Select fluorophores and imaging channels after checking tissue autofluorescence with an appropriate unstained control (standard IF practice). Permeabilisation must allow access to the antibody’s epitope on the cytoplasmic or lumenal side; its side is not specified here (UniProt P35610 topology; datasheet A05096-1). Compare cellular patterns across methods, allowing for their different spatial resolution (standard microscopy practice).
What should I check when DAB background obscures SOAT1-positive cells?
The reported paraffin-section image used 10% goat serum blocking, a 2 μg/ml primary antibody incubation overnight at 4°C, and DAB detection (datasheet A05096-1). Check a no-primary control to locate nonspecific secondary or detection signal, then assess whether blocking, washes or DAB development need adjustment (standard IHC practice). Include a peroxidase-blocking step when using HRP and DAB, because endogenous enzyme activity can create chromogenic signal (standard IHC practice). Compare background with staining in an expected positive cell population on the same run (HPA: High in adrenal zona fasciculata cells; standard IHC practice). Diffuse deposits outside cells should not be scored as SOAT1 (UniProt P35610 localisation; standard IHC practice).
How should I score SOAT1 IHC across samples with different cell mixtures? ⚠ ANSWER MARKED FOR VERIFICATION
Define the cell population and tissue region before scoring, because reported SOAT1 staining differs by cell type (HPA: tissue IHC profile). For chromogenic sections, record the percentage of positive target cells and staining intensity, or calculate an H-score on its 0–300 scale (standard IHC practice). If counting positive cells per mm², normalise to the measured viable tissue area and report the eligible cell population (standard IHC practice). Keep retrieval, imaging and DAB development comparable across slides, using the reported EDTA pH 8.0 retrieval as the starting condition (datasheet A05096-1; standard IHC practice). Exclude necrosis and section edges from the prespecified scoring region (standard IHC practice).
How can I distinguish true SOAT1 staining from a tissue artefact?
A plausible positive shows cellular cytoplasmic staining in an appropriate population, consistent with SOAT1’s endoplasmic reticulum localisation and reported tissue profile (UniProt P35610; HPA: tissue IHC profile). High staining in adrenal zona fasciculata cells is a useful reference, while adipocytes in adipose tissue were reported as not detected (HPA: High in adrenal zona fasciculata cells; HPA: Not detected in adipose adipocytes). Check whether signal instead follows section edges, necrotic areas or extracellular deposits (standard IHC practice). Review no-primary and peroxidase-blocking controls when DAB appears broadly distributed (standard IHC practice). A negative result in one cell population does not establish absence throughout the tissue (HPA: cell-specific tissue IHC profile).
Boster reagents
Best SOAT1 / Sterol O-acyltransferase 1 IHC Antibodies
A05096-1 has real IHC data from human paraffin-embedded breast and prostatic cancer sections and IF data from PC-3 cells (catalog image captions). Its listed reactivity is Human, Mouse and Rat (catalog applications/reactivity).
Real IHC data
Anti-SOAT1 Antibody ®
Cat # A05096-1
The rendered card is A05096-1, with IHC images from human paraffin-embedded breast and prostatic cancer sections (catalog IHC captions). Its IF image shows PC-3 cells (catalog IF caption).
Which to pick: Choose A05096-1 for paraffin-section IHC: its caption documents EDTA retrieval at pH 8.0 and 2 μg/ml primary antibody, but does not report the fixative (A05096-1 IHC caption). For IF/ICC, A05096-1 has a PC-3 cell image at 5 μg/ml; A05096 lists IF at 1:50–1:200 but has no supplied IF image (catalog IF captions/dilutions). Both list Human, Mouse and Rat reactivity, while A05096-1 lists paraffin IHC for Human and Rat and IF/ICC for Human; verify performance in other species and applications before relying on it (catalog applications/reactivity).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry P35610 (SOAT1_HUMAN, Sterol O-acyltransferase 1).
- Human Protein Atlas. SOAT1 tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. SOAT1 subcellular location (ICC-IF): Localized to the endoplasmic reticulum..
- Human Protein Atlas. SOAT1 antibody validation summary (2 antibodies).
- Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma. BMC cancer 2021 — PMC8152151.
- The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures. The Journal of clinical endocrinology and metabolism 2020 — PMC7006231.
- Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess. European journal of endocrinology 2018 — PMC5811932.
- High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer. Prostate cancer and prostatic diseases 2022 — PMC9385470.
- PubMed PMID:8407899 — UniProt-cited evidence.
- PubMed PMID:14702039 — UniProt-cited evidence.
- PubMed PMID:16710414 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for SOAT1 (Sterol O-acyltransferase 1). Expected localisation Cytoplasmic staining in select cells (HPA tissue IHC). Antigen retrieval: EDTA pH 8.0 HIER, heat-mediated (datasheet A05096-1). Validated IHC antibody: A05096-1 at 2-5 μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Adrenal gland (Cells in zona fasciculata); negative Adipose tissue. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded human breast cancer tissue; fixative not specified (datasheet A05096-1); 2. Fixation: Image fixative and duration unreported (datasheet A05096-1); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: EDTA pH 8.0 (datasheet A05096-1); 20 min, 95–100 °C (standard); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A05096-1); 8. Primary antibody: Rabbit anti-SOAT1, 2-5 μg/ml (datasheet A05096-1); 9. Primary incubation: Overnight at 4 °C (datasheet A05096-1). Watch for: Fixation: Keep paraffin-section fixation consistent across samples. (standard IHC practice; not target-specific); Caveat: Staining varies by cell type within a tissue (HPA tissue IHC); Isoform / epitope: Three isoforms; confirm epitope coverage (UniProt); Regulation: No staining-linked regulator annotated (UniProt). Evidence: UniProt P35610, HPA tissue IHC · Enhanced, HPA ICC-IF · endoplasmic reticulum., Datasheet A05096-1, PMC8152151, PMC7006231. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/SOAT1/immunohistochemistry-ihc-guide.